Editor's Note: This article was updated for minor editorial additions and formatting changes, per request of the authors.
Abstract: In order to identify drivers of chronic kidney disease (CKD) stage progression and...
Editor's Note: This article was updated for minor editorial additions and formatting changes, per request of the authors.
Abstract: In order to identify drivers of chronic kidney disease (CKD) stage progression and...
First-line treatment with erlotinib for epidermal growth factor receptor (EGFR) mutation–positive non-small cell lung cancer (NSCLC) patients may have benefits even after disease progresses, a new study...
First-line treatment with erlotinib for epidermal growth factor receptor (EGFR) mutation–positive non-small cell lung cancer (NSCLC) patients may have benefits even after disease progresses, a new study...